Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

125.69 USD -1.59 (-1.25%)
Official Closing Price Updated: 7:59 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Crispr Therapeutics Ag

< Previous 1 2 3 4 Next >
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
From GlobeNewswire News Releases
CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day
From GlobeNewswire News Releases
CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer
From GlobeNewswire News Releases
Thinking about trading options or stock in Axon Enterprise, Tilray, Pfizer, Crispr Therapeutics, or General Motors?
InvestorsObserver issues critical PriceWatch Alerts for AAXN, TLRY, PFE, CRSP, and GM. 
From PR Newswire
Thinking about trading options or stock in Crispr Therapeutics, GameStop, Moderna, Tesla, or FuelCell Energy?
InvestorsObserver issues critical PriceWatch Alerts for CRSP, GME, MRNA, TSLA, and FCEL. 
From PR Newswire
Thinking about trading options or stock in General Electric, Plug Power, Crispr Therapeutics, Vista Outdoor, or Walt Disney?
InvestorsObserver issues critical PriceWatch Alerts for GE, PLUG, CRSP, VSTO, and DIS. 
From PR Newswire
CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV
From GlobeNewswire News Releases
CRISPR Therapeutics and Vertex Present New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at American Society of Hematology Annual Meeting and Exposition, Together With Publication
From GlobeNewswire News Releases
CRISPR Therapeutics and Vertex to Host Investor Webcast to Review Data Presented at the 62nd American Society of Hematology Annual (ASH) Meeting and Exposition for Investigational CRISPR/Cas9 Gene-Edi
From GlobeNewswire News Releases
CRISPR Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
From GlobeNewswire News Releases
CRISPR Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference
From GlobeNewswire News Releases
CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Plenary Presentation at the 62nd American Society of Hematology (ASH) Meeting and Exposition
From GlobeNewswire News Releases
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
CRISPR Therapeutics Reports Positive Top-Line Results from Its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell Malignancies
From GlobeNewswire News Releases
CRISPR Therapeutics Congratulates Co-Founder Emmanuelle Charpentier on Receiving the 2020 Nobel Prize in Chemistry
From GlobeNewswire News Releases
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
From GlobeNewswire News Releases
CRISPR Therapeutics and Vertex Pharmaceuticals Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to CTX001™ for the Treatment of Sickle Cell Disease
From GlobeNewswire News Releases
CRISPR Therapeutics to Present at the Wells Fargo 2020 Virtual Healthcare Conference
From GlobeNewswire News Releases
Thinking about trading options or stock in Tesla, Deere & Company, Penn National Gaming, Palo Alto Networks, or Crispr Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for TSLA, DE, PENN, PANW, and CRSP. 
From PR Newswire
Excision BioTherapeutics Appoints Veteran Genome Editing Expert TJ Cradick, PhD as Chief Scientific Officer
Cradick will lead Excision’s development programs from research to clinical trials 
From GlobeNewswire News Releases
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
From GlobeNewswire News Releases
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results
From GlobeNewswire News Releases
BioMedNewsBreaks – CRISPR Therapeutics (NASDAQ: CRSP) Secures $517.5M in Underwritten Public Offering
From InvestorBrandNetwork
CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares
From GlobeNewswire News Releases
CRISPR Therapeutics Announces Proposed Offering of Common Shares
From GlobeNewswire News Releases
CRISPR Therapeutics and Vertex Announce New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies at the 25th Annual European Hematology Association (EHA) Congres
From GlobeNewswire News Releases
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
From GlobeNewswire News Releases
CRISPR Therapeutics Announces Presentations at the American Association for Cancer Research 2020 Annual Meeting
From GlobeNewswire News Releases
New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Oral Presentation at the 25th European Hematology Association (EHA) Congress
From GlobeNewswire News Releases
CRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX001™ for the Treatment of Severe Hemoglobinopathies
CTX001 has received Orphan Drug Designation from the U.S. Food and Drug Administration for transfusion-dependent beta thalassemia and from the European Medicines Agency for sickle cell disease and... 
From GlobeNewswire News Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback